Marek Anderle

Prix à l'honneur

Legal 500 2025

Recommended lawyer - Dispute Resolution

Marek is a member of the Dispute Resolution team. In addition, he advises national and international clients within the Corporate, M&A and Capital Markets as well as the IP/IT group.

CV

Since 2024 Counsel, Taylor Wessing

2021 – 2023 Senior Associate, Taylor Wessing

2015 – 2021 Associate, Taylor Wessing

Carrière

Since 2024 Counsel, Taylor Wessing

2021 – 2023 Senior Associate, Taylor Wessing

2015 – 2021 Associate, Taylor Wessing

Formation

2018 – 2019 Postgraduate studies in International and Comparative Dispute Resolution (LL.M.), Queen Mary University of London, UK

2013 – 2015 Postgraduate Legal studies, Paneuropean University

2014 Student Exchange Program, University of Turku, Finland

Langues étrangères

Prix et distinctions

Legal 500 2025

Featured

Actualités et publications récentes

View Marek's insights

Cliquer ici pour en savoir plus

Données et cybersécurité

Guide to prevent AI-powered fraud

17 mars 2025

par plusieurs auteurs

Résolution des litiges

Guide to litigation in Slovakia

22 février 2024

In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus

Bratislava

Financovanie startupov alebo „Raise it like Theranos“

12 novembre 2021

18:45 min.

par Marek Anderle, LL.M. et Kristína Kešnerová, LL.M.

Cliquer ici pour en savoir plus

Marek Anderle, LL.M.

Legal 500 2025

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2025

Actualités et publications récentes

Guide to prevent AI-powered fraud

Marek Anderle, LL.M.

Legal 500 2025

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2025

Actualités et publications récentes

Guide to prevent AI-powered fraud

Related news & insights

Taylor Wessing advises Hypax on the carve-out acquisition of the WOLF-Garten business from Stanley Black & Decker

Oli Denne recognised in The Lawyer's Hot 100 2026

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

Advising Toho Global on its acquisition of Anime Limited

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

Key developments in AI disputes in 2025

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

EU Inc.: Founders and companies with expansion plans must now think strategically

Advising Nuclera on its extended Series C funding to US$87 million

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part one

Autres avocats qui pourraient vous intéresser

Rendez-vous à